Source: Annual Congress 2005 - Issues in applied physiology and asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Cremona, E. Baraldi, on behalf of The Italian Nitric Oxide Club, A. Filippo, B. Michele, C. Mario, C. Angelo, C. Fabio, G. Rolando, O. Nicola, P. Umberto, P. Riccardo (Milano, Padova, Italy). Exhaled NO (FENO) is superior to peak-flow monitoring in predicting exacerbation in asthmatics. Eur Respir J 2005; 26: Suppl. 49, 815

Member's Comments

No comment yet.

Related content which might interest you: Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Isocyanate-induced increase of exhaled NO (FeNO) Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006 Exhaled NO (eNO) as a screening test for asthma in children Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002 Exhaled nitric oxide (FENO) in the assessment of the safety of allergen immunotherapy (SIT) in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 209s Year: 2006 Fractional Exhaled NO (FENO) in uncontrolled asthmatics measured with an NO analyzer using dynamic exhalation flow-control Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Exhaled bimarkers in exacerbation of COPD Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007 Measurement of exhaled breath temperature (EBT) in COPD patients Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Il-6 levels in exhaled breath condensate (EBC) of children with moderate well-controlled asthma stepping down inhaled corticosteroids Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017 Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 FeNO (fractional exhaled nitric oxide) measurements in pregnant asthmatic women. The long-term, intra-subject variability of FeNO in controlled asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels Source: International Congress 2017 – Monitoring asthma control Year: 2017 Exhaled breath temperature in patients with severe asthma starting treatment with omalizumab Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Exhaled breath CO and induced sputum in noninvasive assessment of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002